Cronos Group Inc stock page - price, fundamentals, dividends - iOCharts

CRON

5.81
+0.45 (8.40%)
Cronos Group Inc (NASDAQ, USD)
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
2.16B
Ent value
1.45B
Price/Sales
46.22
Price/Book
1.38
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
1.04%
3 year return
-18.29%
5 year return
44.73%
10 year return
-
Last updated: 2021-10-19

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open5.37
Daily high5.83
Daily low5.34
Daily Volume4.65M
All-time high23.70
1y analyst estimate-
Beta1.83
EPS (TTM)-0.20
Dividend per share-
Ex-div date-
Next earnings date4 Nov 2021

Downside potential

Loading...
Downside potential data
CRONS&P500
Current price drop from All-time high-75.49%-0.56%
Highest price drop-80.93%-56.47%
Date of highest drop12 Mar 20209 Mar 2009
Avg drop from high-41.49%-11.45%
Avg time to new high19 days12 days
Max time to new high664 days1805 days

DIVIDENDS

CRON does not pay dividends

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales46.22
Price to Book1.38
EV to Sales30.99

FINANCIALS

Per share

Loading...
Per share data
Current share count371.66M
EPS (TTM)-0.20
FCF per share (TTM)-0.49

Income statement

Loading...
Income statement data
Revenue (TTM)46.72M
Gross profit (TTM)-25.86M
Operating income (TTM)-179.39M
Net income (TTM)-73.14M
EPS (TTM)-0.20
EPS (1y forward)-

Margins

Loading...
Margins data
Gross margin (TTM)-55.36%
Operating margin (TTM)-383.99%
Profit margin (TTM)-156.55%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash1.02B
Net receivables17.51M
Total current assets1.32B
Goodwill179.53M
Intangible assets70.08M
Property, plant and equipment200.66M
Total assets1.88B
Accounts payable29.21M
Short/Current long term debt9.36M
Total current liabilities302.64M
Total liabilities313.00M
Shareholder's equity1.57B
Net tangible assets1.32B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-142.46M
Capital expenditures (TTM)35.39M
Free cash flow (TTM)-177.85M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-4.28%
Return on Assets-3.80%
Return on Invested Capital-4.28%
Cash Return on Invested Capital-10.41%
COMPANY DETAILS
CRON (Cronos Group Inc) company logo
Marketcap
2.16B
Marketcap category
Mid-cap
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Employees
0
SEC filings
CEO
Country
USA
City
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
October 14, 2021
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.
October 10, 2021
While cannabis stocks are blazing with popularity, our survey of readers shows that they are still not willing to commit their portfolios to the risky sector
October 10, 2021
The superstar singer is making a pot play. You can, too.
October 7, 2021
There's little question that marijuana stocks have an opportunity to show investors the green. The easiest way to begin this list is with the cannabis stock that I referred to as the absolute worst p...
September 27, 2021
These are the marijuana stocks on the Nasdaq with the best value, fastest growth, and most momentum for October 2021.
September 8, 2021
Much of the excitement in the marijuana industry today centers around the possibility that the U.S. will legalize cannabis in the near future. Support for legalization has never been higher, with mor...
September 2, 2021
Fractional investing gives small investors an opportunity to consider exposure to large-cap stocks that trade well above $1,000. However, it’s a good idea to also consider buying cheap stocks that cou...
August 31, 2021
When the U.S. government eventually legalizes marijuana, there will undoubtedly be a lot more businesses looking to expand into the growing industry. The current federal ban on pot means that large c...
August 25, 2021
Benzinga’s Cannabis Insider is a live show for cannabis investors. On Tuesday’s show, hosts Patrick Lane and Javier Hasse discussed cannabinoids innovation with Mike Gorenstein, The Cronos Group (NASD...
August 24, 2021
GAINERS: Rhinomed (OTC:RHNMF) shares closed up 25.36% at $0.26 with an estimated market cap of $66,497,992. Leviathan Natural Prods (OTC:LVCNF) shares closed up 24.29% at $0.5 with an estimated market...
Next page